Invention Grant
- Patent Title: 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
- Patent Title (中): 2-嘧啶基吡唑并吡啶ErbB激酶抑制剂
-
Application No.: US12095762Application Date: 2006-12-04
-
Publication No.: US07807673B2Publication Date: 2010-10-05
- Inventor: David Edward Uehling , Robert Dale Hubbard , Alex Gregory Waterson , Kimberly Petrov , Neil Bifulco, Jr. , Joseph Wendell Wilson , Jennifer Gabriel Badiang , Mul Cheung , Mariko Yamabe
- Applicant: David Edward Uehling , Robert Dale Hubbard , Alex Gregory Waterson , Kimberly Petrov , Neil Bifulco, Jr. , Joseph Wendell Wilson , Jennifer Gabriel Badiang , Mul Cheung , Mariko Yamabe
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent J. Scott Young
- International Application: PCT/US2006/046316 WO 20061204
- International Announcement: WO2007/067506 WO 20070614
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437
Abstract:
The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.
Public/Granted literature
- US20090149456A1 2-Pyrimidinyl Pyrazolopyridine ErbB Kinase Inhibitors Public/Granted day:2009-06-11
Information query
